Abstract: Disclosed is an apparatus for monitoring bioaerosols, including a capturer configured to capture bioaerosol particles in air in a capture solution; a particle sprayer configured to electro-spray the capture solution in a form of droplets such that the particles are included in at least some of the sprayed droplets; and an analyzer configured to analyze the particles, sprayed through the particle sprayer, by machine learning. In accordance with such a configuration, the droplets containing a certain amount of the particles can be continuously analyzed in real time by machine learning, thereby contributing to the improvement of monitoring efficiency for a specific bioaerosol genus.

Abstract: Disclosed is an apparatus for capturing bioaerosols. More particularly, the apparatus for capturing bioaerosols includes a sprayer configured to spray a buffer solution for protecting aerosol particles in a form of droplets; and a capturer into which air including the droplets and the aerosol particles is introduced and in a capture solution in which the aerosol particles are captured, wherein discharge members provided with a plurality of nanostructures are provided on a surface of the capturer to charge the aerosol particles. Due to such a configuration, high discharge efficiency can be anticipated even at a low voltage without damage to aerosol particles.

Abstract: The present invention relates to an apparatus for real-time continuous measurement of airborne microorganisms including a body unit, a vaporization unit, a liquefaction unit, a coating unit, and a measurement unit. The body unit has an inlet through which airborne microorganisms are introduced and an outlet through which airborne microorganisms are discharged. The vaporization unit vaporizes a lysis solution and supplies the vaporized lysis solution to the inside of the body unit. The liquefaction unit cools the vaporized lysis solution to condense the vaporized lysis solution on the surfaces of the airborne microorganisms. The coating unit applies a light-emitting agent onto the airborne microorganisms lysed by the lysis solution. The measurement unit detects the intensity of light generated by reacting the airborne microorganisms and the light-emitting agent and measures the concentration of the airborne microorganisms.

Abstract: Disclosed is an apparatus for monitoring bioaerosols, including a capturer configured to capture bioaerosol particles in air in a capture solution; a particle sprayer configured to electro-spray the capture solution in a form of droplets such that the particles are included in at least some of the sprayed droplets; and an analyzer configured to analyze the particles, sprayed through the particle sprayer, by machine learning. In accordance with such a configuration, the droplets containing a certain amount of the particles can be continuously analyzed in real time by machine learning, thereby contributing to the improvement of monitoring efficiency for a specific bioaerosol genus.

Abstract: Disclosed is an apparatus for monitoring bioaerosols. More particularly, the apparatus for monitoring bioaerosols includes a capturer configured to capture bioaerosol particles in air in a capture solution; a first droplet discharger configured to electro-spray the capture solution, in which the particles are captured, in a form of first droplets; a second droplet discharger configured to electro-spray a reagent, capable of reacting with the particles of the first droplets, in a form of second droplets; a reactor in which the first and second droplets are mixed so that the particles react with the reagent; and a measurer configured to measure the particles reacted with the reagent, wherein a size of the first droplets discharged from the first droplet discharger is controlled such that the particles are individually included in the first droplets. In accordance with such a configuration, individual particles can react with a reagent, which allows accurate bioaerosol monitoring with the naked eye.

Abstract: Disclosed is an apparatus for capturing bioaerosols. More particularly, the apparatus for capturing bioaerosols includes a sprayer configured to spray a buffer solution for protecting aerosol particles in a form of droplets; and a capturer into which air including the droplets and the aerosol particles is introduced and in a capture solution in which the aerosol particles are captured, wherein discharge members provided with a plurality of nanostructures are provided on a surface of the capturer to charge the aerosol particles. Due to such a configuration, high discharge efficiency can be anticipated even at a low voltage without damage to aerosol particles.

Abstract: A pathogen detection method includes forming nanoparticles, extracting adenosine triphosphate (ATP) by causing the nanoparticles to collide with pathogens, collecting the pathogens having collided with the nanoparticles, and detecting a light-emitting reaction formed by a reaction with the ATP.

Abstract: A method of preventing damage generated in a microbial aerosolization process is provided. The method includes a first step of injecting microorganisms into an atomizer containing a phosphate-buffered saline (PBS) solution in which one or more selected from the group consisting of ascorbic acid (AA) and bovine serum albumin (BSA) are contained; and a second step of injecting compressed air into an atomizer and spraying a bioaerosol.

Abstract: The present invention relates to an apparatus for real-time continuous measurement of airborne microorganisms including a body unit, a vaporization unit, a liquefaction unit, a coating unit, and a measurement unit. The body unit has an inlet through which airborne microorganisms are introduced and an outlet through which airborne microorganisms are discharged. The vaporization unit vaporizes a lysis solution and supplies the vaporized lysis solution to the inside of the body unit. The liquefaction unit cools the vaporized lysis solution to condense the vaporized lysis solution on the surfaces of the airborne microorganisms. The coating unit applies a light-emitting agent onto the airborne microorganisms lysed by the lysis solution. The measurement unit detects the intensity of light generated by reacting the airborne microorganisms and the light-emitting agent and measures the concentration of the airborne microorganisms.

Abstract: The present invention relates to a method for producing hollow activated carbon nanofibers for activating peroxymonosulfate used in water purification; a catalyst for water purification comprising the hollow active carbon nanofibers produced by the method; and a method for purifying contaminated water using the catalyst. The production method of the present invention can easily produce hollow activated carbon nanofibers capable of rapidly purifying contaminated water by highly efficiently activating peroxymonosulfate used for water purification.

Abstract: The present invention relates to a portable bioaerosol collecting device and an analysis method using the same, and particularly, to a portable bioaerosol collecting device, which includes a first body comprising an air inlet, a second body coupled to the first body and including an air outlet, and a collecting region created by coupling the first and second bodies together.

Abstract: The present invention relates to novel 2,4-pyrimidine derivatives and a use thereof, and more particularly, to pyrimidine derivatives which are effective for systemic lupus erythematosus, a composition for preventing and treating systemic lupus erythematosus comprising the same as an active ingredient and a method for screening the same. The present inventors found novel materials inhibiting surface translocation of gp96 by mimicking a function of AIMP1 which is a molecular anchor for an intracellular residence of gp96, and identified in vitro and in vivo activity of the materials for preventing and treating SLE by alleviating SLE plasma in autoimmune diseases. Therefore, the present invention provides a novel method for screening a therapeutic agent for SLE, and preventing or treating SLE using the mechanism.

Abstract: The present invention relates to novel 2,4-pyrimidine derivatives and a use thereof, and more particularly, to pyrimidine derivatives which are effective for systemic lupus erythematosus, a composition for preventing and treating systemic lupus erythematosus comprising the same as an active ingredient and a method for screening the same. The present inventors found novel materials inhibiting surface translocation of gp96 by mimicking a function of AIMP1 which is a molecular anchor for an intracellular residence of gp96, and identified in vitro and in vivo activity of the materials for preventing and treating SLE by alleviating SLE plasma in autoimmune diseases. Therefore, the present invention provides a novel method for screening a therapeutic agent for SLE, and preventing or treating SLE using the mechanism.